Cited by 114Cholesterol and Lipid MetabolismAtherosclerosis and Cardiovascular DiseasesLipoproteins and Cardiovascular Health

Deficiency of ATP-Binding Cassette Transporters A1 and G1 in Endothelial Cells Accelerates Atherosclerosis in Mice

Open access
Westerterp, Marit, Tsuchiya, Kyoichiro, Tattersall, Ian W., Fotakis, Panagiotis, Bochem, Andrea E., Molusky, Matthew M., Ntonga, Vusisizwe, Abramowicz, Sandra +5 more·2016·Arteriosclerosis, Thrombosis, and Vascular Biology

Abstract

Objective—: Plasma high-density lipoproteins have several putative antiatherogenic effects, including preservation of endothelial functions. This is thought to be mediated, in part, by the ability of high-density lipoproteins to promote cholesterol efflux from endothelial cells (ECs). The ATP-binding cassette transporters A1 and G1 (ABCA1 and ABCG1) interact with high-density lipoproteins to promote cholesterol efflux from ECs. To determine the impact of endothelial cholesterol efflux pathways on atherogenesis, we prepared mice with endothelium-specific knockout of Abca1 and Abcg1 . Approach and Results—: Generation of mice with EC-ABCA1 and ABCG1 deficiency required crossbreeding Abca1 fl/fl Abcg1 fl/fl Ldlr −/− mice with the Tie2Cre strain, followed by irradiation and transplantation of Abca1 fl/fl Abcg1 fl/fl bone marrow to abrogate the effects of macrophage ABCA1 and ABCG1 deficiency induced by Tie2Cre. After 20 to 22 weeks of Western-type diet, both single EC- Abca1 and Abcg1 deficiency increased atherosclerosis in the aortic root and whole aorta. Combined EC- Abca1/g1 deficiency caused a significant further increase in lesion area at both sites. EC- Abca1/g1 deficiency dramatically enhanced macrophage lipid accumulation in the branches of the aorta that are exposed to disturbed blood flow, decreased aortic endothelial NO synthase activity, and increased monocyte infiltration into the atherosclerotic plaque. Abca1/g1 deficiency enhanced lipopolysaccharide-induced inflammatory gene expression in mouse aortic ECs, which was recapitulated by ABCG1 deficiency in human aortic ECs. Conclusions—: These studies provide direct evidence that endothelial cholesterol efflux pathways mediated by ABCA1 and ABCG1 are nonredundant and atheroprotective, reflecting preservation of endothelial NO synthase activity and suppression of endothelial inflammation, especially in regions of disturbed arterial blood flow.

The claims and statistics of this paper haven’t been checked yet.

Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.

A few free checks a day · papers already verified open instantly · results are public

Integrity signals

Registry

Crossref · 10.1161/atvbaha.115.306670

Cites

5 of 5 references verified0 citation errors · 0 not checkable

Statistics

Claims the paper makes

The claims and statistics of this paper haven’t been checked yet.

Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.

A few free checks a day · papers already verified open instantly · results are public

Claims other papers make about this one

Each is checked against this paper’s own text: does it say what the citing paper says it does?

  • Endothelial cell knockout of ABCA1 alone did not result in alterations in new vessel sprouting in a murine model of atherosclerosis, while knockout of ABCG1 did.

    “However, endothelial cell knockout of ABCA1 alone did not result in alterations in new vessel sprouting in a murine model of atherosclerosis, while knockout of ABCG1 did (58).”

    From Cholesterol efflux protein, ABCA1, supports anticancer functions of myeloid immune cells (2026) · cites this paper as [58]

    The Results section ('EC-Abca1 and Abcg1 deficiency enhance new vessel sprouting in aortic rings'; page not provided) reports increased sprouting with endothelial Abcg1 knockout, but not Abca1 knockout. That finding came from an ex vivo aortic-ring assay, not a measurement of sprouting in atherosclerotic lesions; the paper reports no difference in new blood vessels in those lesions. (LLM, conf=0.85)

    Experimental — accuracy not yet measured

Self-check

Percentages, sums and reported differences re-computed from the paper’s own numbers.

The self-check needs the paper’s full text.

Cites

Flagged first, then by citations

Research works printed but not linked: 49

  1. [1]Gordon T Castelli WP Hjortland MC Kannel WB Dawber TR High density lipoprotein as a protective factor against coronary heart disease. The framingham study Am J Med 1977 62 707 714 193398
  2. [2]Voight BF Peloso GM Orho-Melander M Plasma hdl cholesterol and risk of myocardial infarction: A mendelian randomisation study Lancet 2012 380 572 580 22607825 PMC3419820
  3. [4]Murphy AJ Funt S Gorman DJ Tall AR Wang N Pegylation of hdl decreases plasma clearance and enhances anti-atherogenic activity Circ Res 2013 113 e1 e9 23613182 PMC3905798
  4. [5]Plump AS Scott CJ Breslow JL Human apolipoprotein a-i gene expression increases high density lipoprotein and suppresses atherosclerosis in the apolipoprotein e-deficient mouse Proc Natl Acad Sci USA 1994 91 9607 9611 7937814 PMC44862
  5. [6]Nicholls SJ Tuzcu EM Sipahi I Schoenhagen P Crowe T Kapadia S Nissen SE Relationship between atheroma regression and change in lumen size after infusion of apolipoprotein a-i milano J Am Coll Cardiol 2006 47 992 997 16516083
  6. [7]Dansky HM Charlton SA Barlow CB Tamminen M Smith JD Frank JS Breslow JL Apo a-i inhibits foam cell formation in apo e-deficient mice after monocyte adherence to endothelium J Clin Invest 1999 104 31 39 10393696 PMC408406
  7. [8]Tardif JC Gregoire J L'Allier PL Ibrahim R Lesperance J Heinonen TM Kouz S Berry C Basser R Lavoie MA Guertin MC Rodes-Cabau J Effect of r HDLoA-S, Efficacy I Effects of reconstituted high-density lipoprotein infusions on coronary atherosclerosis: A randomized controlled trial JAMA 2007 297 1675 1682 17387133
  8. [9]Assmann G Gotto AM Jr Hdl cholesterol and protective factors in atherosclerosis Circulation 2004 109 III8 III14 15198960
  9. [11]Mineo C Deguchi H Griffin JH Shaul PW Endothelial and antithrombotic actions of hdl Circ Res 2006 98 1352 1364 16763172
  10. [12]d'Uscio LV Smith LA Katusic ZS Hypercholesterolemia impairs endothelium-dependent relaxations in common carotid arteries of apolipoprotein e-deficient mice Stroke 2001 32 2658 2664 11692031
  11. [13]Hajra L Evans AI Chen M Hyduk SJ Collins T Cybulsky MI The nf-kappa b signal transduction pathway in aortic endothelial cells is primed for activation in regions predisposed to atherosclerotic lesion formation Proc Natl Acad Sci USA 2000 97 9052 9057 10922059 PMC16820
  12. [15]Uittenbogaard A Shaul PW Yuhanna IS Blair A Smart EJ High density lipoprotein prevents oxidized low density lipoprotein-induced inhibition of endothelial nitric-oxide synthase localization and activation in caveolae J Biol Chem 2000 275 11278 11283 10753938
  13. [16]Yuhanna IS Zhu Y Cox BE Hahner LD Osborne-Lawrence S Lu P Marcel YL Anderson RG Mendelsohn ME Hobbs HH Shaul PW High-density lipoprotein binding to scavenger receptor-bi activates endothelial nitric oxide synthase Nat Med 2001 7 853 857 11433352
  14. [17]Assanasen C Mineo C Seetharam D Yuhanna IS Marcel YL Connelly MA Williams DL de la Llera-Moya M Shaul PW Silver DL Cholesterol binding, efflux, and a pdz-interacting domain of scavenger receptor-bi mediate hdl-initiated signaling J Clin Invest 2005 115 969 977 15841181 PMC1069105
  15. [18]Terasaka N Yu S Yvan-Charvet L Wang N Mzhavia N Langlois R Pagler T Li R Welch CL Goldberg IJ Tall AR Abcg1 and hdl protect against endothelial dysfunction in mice fed a high-cholesterol diet J Clin Invest 2008 118 3701 3713 18924609 PMC2567835
  16. [19]Zeiher AM Schachlinger V Hohnloser SH Saurbier B Just H Coronary atherosclerotic wall thickening and vascular reactivity in humans. Elevated high-density lipoprotein levels ameliorate abnormal vasoconstriction in early atherosclerosis Circulation 1994 89 2525 2532 8205660
  17. [20]Bisoendial RJ Hovingh GK Levels JH Lerch PG Andresen I Hayden MR Kastelein JJ Stroes ES Restoration of endothelial function by increasing high-density lipoprotein in subjects with isolated low high-density lipoprotein Circulation 2003 107 2944 2948 12771001
  18. [21]Cockerill GW Rye KA Gamble JR Vadas MA Barter PJ High-density lipoproteins inhibit cytokine-induced expression of endothelial cell adhesion molecules Arterioscler Thromb Vasc Biol 1995 15 1987 1994 7583580
  19. [22]Nicholls SJ Dusting GJ Cutri B Bao S Drummond GR Rye KA Barter PJ Reconstituted high-density lipoproteins inhibit the acute pro-oxidant and proinflammatory vascular changes induced by a periarterial collar in normocholesterolemic rabbits Circulation 2005 111 1543 1550 15781735
  20. [23]Wu BJ Chen K Shrestha S Ong KL Barter PJ Rye KA High-density lipoproteins inhibit vascular endothelial inflammation by increasing 3beta-hydroxysteroid-delta24 reductase expression and inducing heme oxygenase-1 Circ Res 2013 112 278 288 23123430
  21. [24]Terasaka N Westerterp M Koetsveld J Fernandez-Hernando C Yvan-Charvet L Wang N Sessa WC Tall AR Atp-binding cassette transporter g1 and high-density lipoprotein promote endothelial no synthesis through a decrease in the interaction of caveolin-1 and endothelial no synthase Arterioscler Thromb Vasc Biol 2010 30 2219 2225 20798376 PMC4790108
  22. [25]Besler C Heinrich K Rohrer L Mechanisms underlying adverse effects of hdl on enos-activating pathways in patients with coronary artery disease J Clin Invest 2011 121 2693 2708 21701070 PMC3223817
  23. [27]Yvan-Charvet L Ranalletta M Wang N Han S Terasaka N Li R Welch C Tall AR Combined deficiency of abca1 and abcg1 promotes foam cell accumulation and accelerates atherosclerosis in mice J Clin Invest 2007 117 3900 3908 17992262 PMC2066200
  24. [28]Westerterp M Koetsveld J Yu S Han S Li R Goldberg IJ Welch CL Tall AR Increased atherosclerosis in mice with vascular atp-binding cassette transporter g1 deficiency Arterioscler Thromb Vasc Biol 2010 30 2103 2105 20705913 PMC3116721
  25. [29]Whetzel AM Sturek JM Nagelin MH Bolick DT Gebre AK Parks JS Bruce AC Skaflen MD Hedrick CC Abcg1 deficiency in mice promotes endothelial activation and monocyte-endothelial interactions Arterioscler Thromb Vasc Biol 2010 30 809 817 20110576 PMC2862679
  26. [30]Zhu M Fu Y Hou Y Wang N Guan Y Tang C Shyy JY Zhu Y Laminar shear stress regulates liver x receptor in vascular endothelial cells Arterioscler Thromb Vasc Biol 2008 28 527 533 18096827
  27. [31]Erbilgin A Siemers N Kayne P Yang WP Berliner J Lusis AJ Gene expression analyses of mouse aortic endothelium in response to atherogenic stimuli Arterioscler Thromb Vasc Biol 2013 33 2509 2517 23990205 PMC4105212
  28. [32]Fang L Choi SH Baek JS Liu C Almazan F Ulrich F Wiesner P Taleb A Deer E Pattison J Torres-Vazquez J Li AC Miller YI Control of angiogenesis by aibp-mediated cholesterol efflux Nature 2013 498 118 122 23719382 PMC3760669
  29. [33]Westerterp M Murphy AJ Wang M Deficiency of atp-binding cassette transporters a1 and g1 in macrophages increases inflammation and accelerates atherosclerosis in mice Circ Res 2013 112 1456 1465 23572498 PMC3839866
  30. [34]Alva JA Zovein AC Monvoisin A Murphy T Salazar A Harvey NL Carmeliet P Iruela-Arispe ML Ve-cadherin-cre-recombinase transgenic mouse: A tool for lineage analysis and gene deletion in endothelial cells Dev Dyn 2006 235 759 767 16450386
  31. [35]Kisanuki YY Hammer RE Miyazaki J Williams SC Richardson JA Yanagisawa M Tie2-cre transgenic mice: A new model for endothelial cell-lineage analysis in vivo Dev Biol 2001 230 230 242 11161575
  32. [36]Kanda T Brown JD Orasanu G Vogel S Gonzalez FJ Sartoretto J Michel T Plutzky J Ppargamma in the endothelium regulates metabolic responses to high-fat diet in mice J Clin Invest 2009 119 110 124 19065047 PMC2613459
  33. [37]Rask-Madsen C Li Q Freund B Loss of insulin signaling in vascular endothelial cells accelerates atherosclerosis in apolipoprotein e null mice Cell Metab 2010 11 379 389 20444418 PMC3020149
  34. [38]Chambliss KL Yuhanna IS Mineo C Liu P German Z Sherman TS Mendelsohn ME Anderson RG Shaul PW Estrogen receptor alpha and endothelial nitric oxide synthase are organized into a functional signaling module in caveolae Circ Res 2000 87 E44 E52 11090554
  35. [39]Kuhlencordt PJ Gyurko R Han F Scherrer-Crosbie M Aretz TH Hajjar R Picard MH Huang PL Accelerated atherosclerosis, aortic aneurysm formation, and ischemic heart disease in apolipoprotein e/endothelial nitric oxide synthase double-knockout mice Circulation 2001 104 448 454 11468208
  36. [40]Tacke F Alvarez D Kaplan TJ Jakubzick C Spanbroek R Llodra J Garin A Liu J Mack M van Rooijen N Lira SA Habenicht AJ Randolph GJ Monocyte subsets differentially employ ccr2, ccr5, and cx3cr1 to accumulate within atherosclerotic plaques J Clin Invest 2007 117 185 194 17200718 PMC1716202
  37. [41]De Caterina R Libby P Peng HB Thannickal VJ Rajavashisth TB Gimbrone MA Jr Shin WS Liao JK Nitric oxide decreases cytokine-induced endothelial activation. Nitric oxide selectively reduces endothelial expression of adhesion molecules and proinflammatory cytokines J Clin Invest 1995 96 60 68 7542286 PMC185173
  38. [42]Millauer B Wizigmann-Voos S Schnurch H Martinez R Moller NP Risau W Ullrich A High affinity vegf binding and developmental expression suggest flk-1 as a major regulator of vasculogenesis and angiogenesis Cell 1993 72 835 846 7681362
  39. [43]Moulton KS Heller E Konerding MA Flynn E Palinski W Folkman J Angiogenesis inhibitors endostatin or tnp-470 reduce intimal neovascularization and plaque growth in apolipoprotein e-deficient mice Circulation 1999 99 1726 1732 10190883
  40. [44]Gariano RF Gardner TW Retinal angiogenesis in development and disease Nature 2005 438 960 966 16355161
  41. [45]Bi X Zhu X Gao C Shewale S Cao Q Liu M Boudyguina E Gebre AK Wilson MD Brown AL Parks JS Myeloid cell-specific atp-binding cassette transporter a1 deletion has minimal impact on atherogenesis in atherogenic diet-fed low-density lipoprotein receptor knockout mice Arterioscler Thromb Vasc Biol 2014 34 1888 1899 24833800 PMC4140956
  42. [47]Out R Hoekstra M Habets K Meurs I de Waard V Hildebrand RB Wang Y Chimini G Kuiper J Van Berkel TJ Van Eck M Combined deletion of macrophage abca1 and abcg1 leads to massive lipid accumulation in tissue macrophages and distinct atherosclerosis at relatively low plasma cholesterol levels Arterioscler Thromb Vasc Biol 2008 28 258 264 18006857
  43. [48]Spann NJ Garmire LX McDonald JG Regulated accumulation of desmosterol integrates macrophage lipid metabolism and inflammatory responses Cell 2012 151 138 152 23021221 PMC3464914
  44. [49]Vaisman BL Demosky SJ Stonik JA Ghias M Knapper CL Sampson ML Dai C Levine SJ Remaley AT Endothelial expression of human abca1 in mice increases plasma hdl cholesterol and reduces diet-induced atherosclerosis J Lipid Res 2012 53 158 167 22039582 PMC3243472
  45. [50]Trigatti B Rayburn H Vinals M Braun A Miettinen H Penman M Hertz M Schrenzel M Amigo L Rigotti A Krieger M Influence of the high density lipoprotein receptor sr-bi on reproductive and cardiovascular pathophysiology Proc Natl Acad Sci USA 1999 96 9322 9327 10430941 PMC17781
  46. [51]Yvan-Charvet L Welch C Pagler TA Ranalletta M Lamkanfi M Han S Ishibashi M Li R Wang N Tall AR Increased inflammatory gene expression in abc transporter-deficient macrophages: Free cholesterol accumulation, increased signaling via toll-like receptors, and neutrophil infiltration of atherosclerotic lesions Circulation 2008 118 1837 1847 18852364 PMC2756536
  47. [52]Wang N Ranalletta M Matsuura F Peng F Tall AR Lxr-induced redistribution of abcg1 to plasma membrane in macrophages enhances cholesterol mass efflux to hdl Arterioscler Thromb Vasc Biol 2006 26 1310 1316 16556852
  48. [53]Tarling EJ Edwards PA Atp binding cassette transporter g1 (abcg1) is an intracellular sterol transporter Proc Natl Acad Sci USA 2011 108 19719 19724 22095132 PMC3241749
  49. [54]Gille A Easton R D'Andrea D Wright SD Shear C Csl112 enhances biomarkers of reverse cholesterol transport after single and multiple infusions in healthy subjects Arterioscler Thromb Vasc Biol 2014 34 2106 2114 24969776

Cited by

Sorted by citations

Authors
Westerterp, M., Tsuchiya, K., Tattersall, I. W., Fotakis, P., Bochem, A. E., Molusky, M. M., Ntonga, V., Abramowicz, S., Parks, J. S., Welch, C. L., Kitajewski, J., Accili, D., & Tall, A. R.
Affiliations
Tokyo Medical and Dental University (JP)
Corresponding author
Westerterp, Marit
Venue
Arteriosclerosis, Thrombosis, and Vascular Biology
Published
2016-07
Volume
36
Issue
7
Pages
1328-1337
ISSN
  • 1079-5642 (ISSN-L)
  • 1524-4636
OpenAlex
W2403798563
Cited by
114
References
5
Citations by year
2026: 5 · 2025: 7 · 2024: 8 · 2023: 13 · 2022: 13 · 2021: 9 · 2020: 19 · 2019: 9 · 2018: 20 · 2017: 8 · 2016: 3
FWCI
14.77
Type
journal article
Language
en
Open access
Locations
  • Arteriosclerosis Thrombosis and Vascular Biology (publishedVersion)
  • PubMed (publishedVersion)
  • PubMed Central (acceptedVersion)
  • University of Groningen research database (University of Groningen / Centre for Information Technology) (submittedVersion)
Funders
  • National Heart, Lung, and Blood Institute (R01HL119043, R01HL119962, P01HL087123, R01HL112626, R01HL107653, T32HL007343)
  • National Center for Research Resources (S10RR027050)
Topics
  • Health Sciences › Medicine › Surgery › Cholesterol and Lipid Metabolism
  • Life Sciences › Immunology and Microbiology › Immunology › Atherosclerosis and Cardiovascular Diseases
  • Health Sciences › Medicine › Surgery › Lipoproteins and Cardiovascular Health
Keywords
ABCA1, ABCG1, ABC transporters, endothelial cells, atherosclerosis, cholesterol efflux, high-density lipoprotein, endothelial nitric oxide synthase, endothelial inflammation, disturbed blood flow, macrophage lipid accumulation, monocyte infiltration, lipopolysaccharide, aortic plaque
MeSH terms
ATP Binding Cassette Transporter, Subfamily G, Member 1, Animals, Aorta, Thoracic, Aortic Diseases, Cholesterol, Disease Models, Animal, Macrophages, Male, Monocytes, Phenotype, Receptors, LDL, Regional Blood Flow, Time Factors, Whole-Body Irradiation, Retinal Neovascularization, Bone Marrow Transplantation, Mice, Knockout, Disease Progression, Inflammation Mediators, Neovascularization, Physiologic, Genetic Predisposition to Disease, Endothelial Cells, Tissue Culture Techniques, Atherosclerosis, Nitric Oxide Synthase Type III, Plaque, Atherosclerotic, Diet, High-Fat, ATP Binding Cassette Transporter 1

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review